What You Should Know:
– Medtronic, the global leader in medical technology, announced the launch of InPen integrated with real-time Guardian Connect Continuous Glucose Monitoring (CGM) data.
– InPen is the first and only FDA-cleared smart insulin pen on the market for people on multiple daily injections (MDI).
– The combined solution now provides real-time glucose readings alongside insulin dose information giving users everything they need to manage their diabetes in one view.
– The InPen app will continue to display information from other currently compatible CGM systems on a three-hour delay.
– The integration of real-time CGM data into the smart insulin pen app is a result of the addition of Companion Medical’s InPen to the Medtronic portfolio, as of September 2020.
